Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


GREY:CRRVF - Post by User

Bullboard Posts
Post by buyifisell1on Sep 03, 2019 5:46pm
138 Views
Post# 30092137

CVR's to-do list

CVR's to-do list
If CVR is to survive, I believe there are a number of things it needs to do.

1. It needs to start behaving like a regular company that follows the rules. That means getting any required filings submitted on time - not just financial statements but press releases as well. Companies are required to send out a PR when there is substantial news, which it clearly did not do following the FDA's rejection of its application back in May.

2. It needs to make all of its business relationships crystal clear.  What is the relationship between CVR Golbal and CVR medical?  Who are the major shareholders in the CVRs and how much do they hold (starting with our current CEO), so we know who is really running the show? What loans do they have with officers/directors/other individuals?

3. It needs to find a way to fund the company without massive share dilution. The best way may be for CVR to sell rights to the device in markets outside of Canada/US. While doing business in China is always tricky, they have a much higher rate of cardiovascular issues than the rest of the world and may top the list.

They need to get 1 and 2 done first or there is no hope of getting 3 done.

Bullboard Posts